How long does it take to take Cabergoline to restore pregnancy and childbirth safety?

Cabergoline (Cabergoline) is a dopamine receptor agonist commonly used to treat menstrual disorders, ovulation disorders and infertility problems caused by hyperprolactinemia (hyperprolactinemia). This drug gradually restores ovulation function by inhibiting the secretion of prolactin from the pituitary gland, thereby increasing the chance of pregnancy. Generally speaking, some patients can resume ovulation within 4~8 weeks after starting the medication. If the dose of the drug is appropriate and the individual responds well, the chance of pregnancy will increase significantly within 2~3 months. However, recovery rates vary based on individual differences, severity of illness, and medication compliance.

When trying to conceive, it is usually recommended to wait one month after stopping medication before trying to conceive. This is because although cabergoline has a long half-life (approximately 63～69 hours), it takes some time for drug metabolism and hormone levels in the body to return to a stable state after stopping the drug. Most studies show that stopping the drug to conceive after 1 month does not increase the risk of fetal malformation or miscarriage. However, there is no need to panic if you become pregnant unexpectedly while taking the drug. A large amount of clinical data has confirmed that early use of cabergoline has minimal impact on fetal development, and the birth defect rate is not significantly different from that of the general population.

In terms of safety, cabergoline is considered one of the safer ovulation induction and prolactin-lowering drugs. According to information from the European Society of Endocrinology and the U.S. FDA, cabergoline has not been found to significantly increase the risk of fetal malformation, miscarriage or premature birth in women who are used to treat infertility. Its safety is better than that of early bromocriptine (Bromocriptine), and it is better tolerated by patients. Side effects such as dizziness and nausea are mostly mild and can be alleviated over time. Doctors usually gradually reduce or discontinue the drug based on prolactin levels to ensure a stable hormonal environment before planning a pregnancy.

In general, most patients can recover their ovulation function within weeks to months after taking cabergoline, and it is safer to become pregnant 1 months after stopping the drug. Throughout the entire pregnancy preparation and pregnancy process, prolactin levels and ovarian function should be monitored regularly, and the dosage should be adjusted according to the physician's guidance. If the pregnancy is successful, the medication should be stopped in time and followed up by an endocrinologist and obstetrician to ensure the health of the mother and fetus. Scientific use of cabergoline can not only improve fertility, but also bring a safe and reliable treatment option for infertile women with hyperprolactinemia.

Reference materials:https://www.drugs.com/